Abstract
The hypothesis that estrogen is an important promoter of carcinogenically induced mammary neoplasia opens up some attractive possibilities for prevention of some, most, or all clinical breast cancers. This chapter will explore the evidence in support of such a hypothesis and examine the logistic possibilities of undertaking a clinical trial to test for endocrine prevention of breast cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Asch, R.H. and Greenblatt, R.B. (1977) The use of an impeded androgen—danazol—in the management of benign breast disorders. Am. J. Obstet. Gynae. 127:130–134.
Bulbrook, R.D., Moore, J.W., Clarke, G.M.G. and Wang, D.Y. (1986) Guernsey prospective study: relation between risk of breast cancer and biological availability of blood oestradiol. Ann. N.Y. Acad. Sci.
Davis, H.H., Simons, M. and Davis, J.B. (1964) Cystic disease of the breast—relationship to carcinoma. Cancer 17:957–978.
Dupont, W.D. and Page, D.L. (1985) Risk factors for breast cancer in women with proliferative breast disease. New Eng. J. Med. 312:146–151.
Fentiman, I.S., Caleffi, M., Brame, K., Chandary, M.A., Hayward, J.L. Double blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1:287–288.
Foote, F.W. and Stewart, F.W. (1945) Comparative studies of carcinoma versus noncancerous breasts. Role of chronic cystic mastitis in mammary carcinogensis. Ann. Surg. 121:197–204.
Frantz, V.K., Picken, J.W., Melcher, G.W. et al. (1981) Incidence of chronic cystic disease in so-called normal breasts—a study based on 225 PM examinations. Cancer 4:762–782.
Golinger, R.C. (1978) Hormones and the pathophysiology of fibrocystic mastopathy. Surg. Gynae. Obstet. 146:273–285.
Gravelle, I.H., Bulstrode, J.C, Wang, D.Y. and Hayward, J.L. (1980) The relation between radiological features and determinants of risk of breast cancer. Br. J. Radiol. 53:107–113.
Haagensen, CD. (1971) Cystic disease of the breast. In Diseases of the Breast CD. Haagensen, (ed.). W.B. Saunders, pp. 155–176.
Hirayama, T. and Wynder, E.L. (1962) Study of epidemology of cancer of the breast. Influence of hysterectomy. Cancer 15:28–38.
Jordan, V.C., Naylor, K.E., Dix, C.J. and Prestwich, G. (1980) Antiestrogen in experimental breast cancer. Recent Results in Cancer Research: 31–44.
Jordan, V.C. (1981) Comparative antiestorgen in experimental breast cancer. Adv. Exp. Med. Biol. 138:165–78.
Kelsey, J.L. (1979) A review of the epidemiology of human breast cancer. Epidem. Reviews 1:74–109.
MacMahon, B. and Feinlieb, M. (1960) Breast cancer in relation to nursing and menopausal history. J. Natl. Cancer Inst. 24:733–753.
Mansel, R.E., Wisbey, J.R. and Hughes, L.E. (1982) Controlled trial of Danazol in painful nodular benign breast disease. Lancet 1:928–931.
Marvais-Jarvis, P., Sitruk-Ware, R., and Kuttenn, F. (1982) Luteal phase effect and breast cancer genesis. Br. Can. Res. Treat. 2:139–150.
Miller, A.B., and Bulbrook, R.D. (1980) The epidemiology and etiology of breast cancer. New Eng. J. Med. 303:1246–1248.
Moore, J.W., Clark, G.M.G., Bulbrook, R.D., Hayward, J.L., Murai, J.T., Hammond, G.L., and Siiteri, P.K. (1982) Serum concentration of total and non-protein-bound oestra-diol in patients with breast cancers and in normal controls. Int. J. Cancer 29:17–21.
Nathanson, I.T. (1946) Present concepts of benign breast disease. N. Eng. J. Med. 235:516–520.
Page, D.L., Vander, Z.R., Rogers, L.W., Williams, L.T., Walker, W.E. and Hartman, W.M. (1978) Relation between component parts of fibrocystic disease and breast cancer. J. Nat. Cancer Inst. 61:1055–1063.
Pinotti, J. A., Tolosa, H.A., and Sivini, F. (1979) Experimental use of an antiestrogen in the treatment of patients with mammary dysplasia not responding to other treatments. J. Bras. Ginec. 1:57–59.
Pons, J.Y. and Huber, C.J. (1978) Fibrocystic disease of the breast. In Breast Disease D.J. Marchant and I. Nyirjesy (eds.). Grune and Stratton, pp. 20–30
Powles, T. et al. (1986) A randomised clinical trial to compare tamoxifen and danazol for treatment of benign mammary dysplasia.
Pye, J.K., Mansel, R.E. and Hughes, L.E. (1985) Clinical experience of drug treatments for mastalgia. Lancet 2:373–377.
Ricciardi, I. and Ianniruberto, A. (1979) Tamoxifen-induced regression of benign breast lesions. Obstet, & Gynae. 54:80–84.
Roberts, M.M., Jones, V., Elton, R.A., Fortt, R.W., Williams, S. and Gravelle, I.H. (1984) Risk of breast cancer in women with history of benign breast disease. British Medical Journal 288:275–278.
Shaaban, M.M., Morad, F. and Hassan, A.R. Treatment of fibrocystic mastopathy by an antiestrogen, tamoxifen. Int. J. Gynae. Obstet. 18:348–350.
Sherman, B.M. and Korenman, S.G. (1974) Inadequate corpus leteum function. A pathophysiological interpretation of human breast cancer epidemiology. Cancer 33:1306–1312.
Tokunaga, M., Norman, J.E., Asano, M. et al. (1979) Malignant breast tumors among Atomic Bomb Survivors, Hiroshima and Nagasaki, 1950–74. JNCI 62:1347–1359.
Tokunaga, M., Land, C.E., Yamamato, T., Asano, M., Tokuoka, S., Ezaki, H, Nishimori, I., Fujikura, T. (1984) Breast cancer among atomic bomb survivors. In Radiation Carcinogenesis: Epidemiology and Biological Significance J.D. Boice and J.F. Fraumeni (eds.). New York: Publ. Raven Press.
Wang, D.Y. and Fentiman, I.S. (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res. Treat. 6:5–36.
Wolfe, J. (1976) Risk for breast cancer development determined by mammographic paren-chmyal patterns. Cancer 37:2486–2492.
Zelenik, J.S. (1964) Clomiphene in chronic cystic disease of the breast. Am. J. Obstet. Gynae. 89:110.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Powles, T. (1987). Endocrine Prevention of Breast Cancer by Tamoxifen. In: Paterson, A.H.G., Lees, A.W. (eds) Fundamental Problems in Breast Cancer. Developments in Oncology, vol 51. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2049-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2049-4_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9218-0
Online ISBN: 978-1-4613-2049-4
eBook Packages: Springer Book Archive